NIJ FY25 Research and Development in Forensic Science for Criminal Justice Purposes
ID: 358277Type: Posted
Overview

Buyer

National Institute of Justice (USDOJ-OJP-NIJ)

Award Range

$0 - $13M

Eligible Applicants

Others

Funding Category

Science and Technology and other Research and Development

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/358277

Additional Information

https://nij.ojp.gov/funding/opportunities/o-nij-2025-172351
Timeline
    Description

    The National Institute of Justice (NIJ) is offering a funding opportunity titled "NIJ FY25 Research and Development in Forensic Science for Criminal Justice Purposes." This grant aims to support basic or applied research and development in forensic science, addressing current research priorities and technology challenges identified by NIJ's Forensic Science Strategic Research Plan. The initiative is crucial for enhancing the capabilities of the criminal justice community to enforce laws, promote public safety, and ensure fair administration of justice. The total estimated program funding is $12.5 million, with no cost-sharing requirement, and applications are due by April 2, 2025. For technical assistance, applicants can contact the NIJ at grants@ncjrs.gov or call the OJP Response Center at 800-851-3420.

    Point(s) of Contact
    grants@ncjrs.gov
    Files
    No associated files provided.
    Similar Opportunities
    FY 2025 NIST Small Business Innovation Research Program Phase II
    National Institute of Standards and Technology
    The National Institute of Standards and Technology (NIST) is inviting applications for the FY 2025 Small Business Innovation Research (SBIR) Program Phase II, specifically targeting previous Phase I award recipients from FY 2024. This opportunity aims to support the development of market-ready products or services, with a focus on enhancing innovation in federally funded research and development, while also addressing federal R&D needs through small businesses. NIST anticipates funding approximately five awards, each up to $400,000 over a 24-month project period, with applications due by June 14, 2025, submitted via Grants.gov. For further inquiries, applicants can contact Misty Roosa at Grants@nist.gov.
    Joint NINDS/NIMH Exploratory Neuroscience Research Grant (R21 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Joint NINDS/NIMH Exploratory Neuroscience Research Grant (R21 Clinical Trial Not Allowed) to support innovative and exploratory research projects in neuroscience. This grant program is designed for early-stage projects that align with the missions of the National Institute of Neurological Disorders and Stroke (NINDS) and the National Institute of Mental Health (NIMH), focusing on studies that assess the feasibility of novel investigations with the potential for significant breakthroughs in neuroscience. Eligible applicants include a wide range of organizations such as educational institutions, nonprofits, and foreign entities, with funding available up to $275,000 over two years. The application period opens on January 16, 2025, with anticipated awards by July 2025; interested parties can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Cancer Institute (NCI), is offering a funding opportunity titled "NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional)" aimed at supporting innovative preclinical and early-phase clinical research in cancer diagnosis, treatment, and prevention. This grant, with a funding ceiling of $275,000 over two years, encourages exploratory studies that may involve significant risk but have the potential to lead to breakthroughs in cancer research, particularly for underserved populations. Applications will be evaluated based on their significance, innovation, and rigor, with key deadlines for submission set for January 2025. Interested applicants can find more information and contact NIH Grants Information at grantsinfo@nih.gov for inquiries.
    Technology Development Research for Establishing Feasibility and Proof of Concept (R21 - Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled “Technology Development Research for Establishing Feasibility and Proof of Concept (R21 - Clinical Trial Not Allowed),” aimed at supporting exploratory research for innovative biomedical technologies. This initiative focuses on high-risk projects that have not yet established feasibility, specifically targeting the development of tools such as laboratory instruments, algorithms, and chemical reagents, while excluding applications that address specific biological questions or present existing proof of concept data. Eligible applicants can request funding of up to $275,000 over two years, with a maximum of $200,000 in any single year, and applications are due by May 7, 2025. For further details, interested parties can contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov or refer to the full announcement at http://grants.nih.gov/grants/guide/pa-files/PAR-22-126.html.
    Nursing Research Education Program in Firearm Injury Prevention Research: Short Courses (R25 Independent Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a grant opportunity titled "Nursing Research Education Program in Firearm Injury Prevention Research: Short Courses," aimed at enhancing the training of nurse scientists and related fields in firearm injury prevention. This program seeks to develop and implement short courses (ranging from 2 to 12 weeks) that focus on evidence-based interventions, health equity, and the social determinants of firearm injuries, with an emphasis on addressing inequities across various demographics. Eligible applicants include a diverse range of organizations such as higher education institutions, nonprofits, and government agencies, particularly those serving historically underrepresented groups, with funding available up to $200,000 per year for a maximum of three years. Applications are due by January 25, 2024, and interested parties can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    NIAID, NIDDK, NIDA, and NIAAA Research Opportunities for New and "At-Risk" Investigators (R01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "NIAID, NIDDK, NIDA, and NIAAA Research Opportunities for New and 'At-Risk' Investigators (R01 Clinical Trial Optional)" aimed at supporting research projects in health-related fields. This initiative specifically targets New Investigators who have not previously secured substantial NIH funding and 'At-Risk' Investigators who may lose their funding, encouraging applications from diverse backgrounds to promote equity in the scientific workforce. The program is crucial for addressing health disparities through innovative research in areas such as infectious diseases, diabetes, drug abuse, and alcohol use. Applications will be accepted starting January 5, 2025, with a maximum project period of five years, and interested applicants can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries. The opportunity does not require cost-sharing or matching and is categorized under discretionary funding with a CFDA number of 93.855.
    Investigator Initiated Innovation in Computational Genomics and Data Science (R21 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Investigator Initiated Innovation in Computational Genomics and Data Science (R21 Clinical Trial Not Allowed)" aimed at advancing research in computational genomics, bioinformatics, and data visualization methodologies that enhance genomic science and its application to human health. This initiative seeks innovative projects that develop novel analytical tools and methodologies, with a budget limit of $275,000 for a two-year project period, focusing on scalable solutions applicable across various diseases and biological systems. The funding is particularly targeted at underrepresented entities in genomic research, including higher education institutions, nonprofits, and governmental bodies, reflecting NIH's commitment to fostering collaborative research in this critical field. Interested applicants should note that key submission dates begin on January 16, 2025, with a final expiration date of September 8, 2027, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Notice of Intent to Publish a Funding Opportunity Announcement for Accelerating the Pace of Substance Use Research Using Existing Data (R21 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to publish a Notice of Funding Opportunity (NOFO) aimed at accelerating substance use research through the utilization of existing data, specifically under the R21 grant mechanism. This initiative seeks to foster innovative research projects that leverage pre-existing datasets to enhance understanding and treatment of substance use disorders. The total estimated funding for this program is $2 million, with an award ceiling of $200,000 per project and an anticipated three awards to be made. Interested applicants should note that the NOFO is expected to be published in Fall 2024, with applications due in Spring 2025, and the estimated award date is set for April 1, 2026.
    Notice of Intent to Publish a Funding Opportunity for NIDA REI: Racial Equity Visionary Award Program for Research on Substance Use and Racial Equity (DP1 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is forecasting a funding opportunity titled "NIDA REI: Racial Equity Visionary Award Program for Research on Substance Use and Racial Equity," which aims to support research initiatives that address the intersection of substance use and racial equity. This grant program, utilizing the DP1 activity code, is designed to foster meaningful collaborations and innovative projects in this critical area of health research. With an estimated total program funding of $3.5 million and an award ceiling of $700,000, the anticipated application period will open in Fall 2025, following the expected publication of the notice of funding opportunity in Spring 2025. Interested applicants should prepare to submit their proposals by the estimated closing date of October 14, 2025, with awards expected to be made by July 1, 2026.
    Measurement Science and Engineering (MSE) Research Grant Programs
    National Institute of Standards and Technology
    The National Institute of Standards and Technology (NIST) is offering the Measurement Science and Engineering (MSE) Research Grant Programs for Fiscal Year 2024, aimed at advancing measurement science and standards across various fields such as biotechnology, advanced manufacturing, and cybersecurity. This funding opportunity, identified as NOFO Number 2024-NIST-MSE-01, is open to a wide range of non-Federal entities, including institutions of higher education, non-profit organizations, for-profit organizations, state and local governments, and Indian tribes, with no cost-sharing requirement for applicants. The grants are intended to foster collaboration, workforce development, and technical innovation, thereby enhancing U.S. competitiveness and promoting diversity in research. Interested applicants can submit their proposals on a rolling basis via Grants.gov, with the application deadline set for March 5, 2026. For further inquiries, applicants may contact Misty Roosa at Grants@nist.gov.